BACKGROUND: There are few reports of miscarriages or stillbirths in women infected with SARS-CoV-2. We present five consecutive cases of fetal death (≥12 weeks) without other putative causes in women with laboratory-confirmed (RT-PCR) COVID-19 managed in a single Brazilian institution. CASE SERIES: All five women were outpatients with mild or moderate forms of COVID-19 and…
Case Reports in Women s Health Template
Write in a clean editor, then format for Case Reports in Women s Health in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Case Reports in Women s Health format
Case Reports in Women s Health is a peer-reviewed journal published by Elsevier, covering Maternal and fetal healthcare, Ectopic Pregnancy Diagnosis and Management, Uterine Myomas and Treatments.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Case Reports in Women s Health 12 (2023) 45–58.
Formats any DOI in Case Reports in Women s Health style. No sign-up. |
| Publishes research in | Maternal and fetal healthcare Ectopic Pregnancy Diagnosis and Management Uterine Myomas and Treatments Gynecological conditions and treatments Endometriosis Research and Treatment |
| ISSN | 2214-9112 |
| Citation impact (2-yr) | 0.75 |
| h-index | 21 |
| i10-index | 84 |
| Total citations | 3,399 |
| Article processing charge | $550 |
| Open access | Yes |
| Top institutions publishing here | University of the Witwatersrand |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Case Reports in Women s Health per year
Citation impact of Case Reports in Women s Health by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Case Reports in Women s Health
Remdesivir is a novel therapeutic with known activity against SARS CoV-2 and related coronaviruses. Remdesivir, as well as convalescent plasma therapy, are currently under investigation as potential therapies for patients with Coronavirus Disease 19 (COVID-19). In this case report we summarize the use of convalescent plasma therapy and then remdesivir as a late addition in…
BACKGROUND: Coronavirus-2019 (COVID-19) is a global health crisis, but there is limited guidance for the critical care management of pregnant patients experiencing respiratory collapse. We describe our management of a peri-viable pregnant patient requiring intubation; discussion includes pharmacologic interventions, mechanical ventilation adjustments, and consideration of fetal interventions, including delivery timing. CASE: A 36-year-old, gravida 2,…
BACKGROUND: The coronavirus 2019 (COVID-19) pandemic has posed unique challenges in healthcare. In obstetrics, there is little information available to guide practice. As new data emerge, the spectrum of initial presenting symptoms has expanded from fever, cough, and dyspnea to gastrointestinal and other symptoms in both pregnant and non-pregnant patients. CASE: A 36-year-old woman, G4P2,…